WSC 2024, Abu Dhabi - EVER Symposium

The World Stroke Congress (WSC), held in October 2024 in Abu Dhabi, united leading experts, clinicians and researchers from around the globe to discuss the latest developments in stroke treatment, rehabilitation and recovery.

The official symposium of EVER Pharma featured two pivotal lectures on stroke treatment. Dr. Ahmed ElBassiouny presented the role of add-on therapies following mechanical thrombectomy (MT) in patients with embolic stroke, emphasizing strategies to enhance recovery outcomes. Prof. Michael Brainin presented the design of the C-REGS2 study, a large-scale comparative effectiveness trial to evaluate the most effective post-stroke treatment approaches.

Chair: Steven Zeiler (USA)

• Add-on therapy following MT in patients with embolic stroke
  Ahmed El Bassiouny (Egypt)
• C-REGS2 – First results of a large high-quality comparative effectiveness study
  Michael Brainin (Austria)

Read the detailed symposium report below!